You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Thrombocythemia, Essential

Showing 26 - 50 of 4,778
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Essential Thrombocythemia, Polycythemia Vera, Primary Myelofibrosis Trial in Buffalo (drug, dietary supplement, other)

Terminated
  • Essential Thrombocythemia
  • +2 more
  • Arsenic Trioxide
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)

Recruiting
  • Primary Myelofibrosis
  • +9 more
  • Observational
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 11, 2022

Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,

Recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 18, 2022

Myelofibrosis, Post-polycythemia Vera Myelofibrosis (PPV-MF), Post-essential Thrombocythemia Myelofibrosis (PET-MF) Trial in

Completed
  • Myelofibrosis
  • +3 more
  • Ann Arbor, Michigan
  • +4 more
Mar 28, 2022

Myeloproliferative Tumor, Essential Thrombocythemia, JAK2 Mutation Trial in Ottawa (Apixaban 2.5 MG Oral Tablet [ELIQUIS],

Recruiting
  • Myeloproliferative Neoplasm
  • +5 more
  • Apixaban 2.5 MG Oral Tablet [ELIQUIS]
  • Aspirin 81 mg
  • Ottawa, Ontario, Canada
    The Ottawa Hospital
Apr 19, 2022

Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Small Lymphocytic Lymphoma Trial in Baltimore (Fludarabine,

Completed
Has Results
  • Myelodysplastic Syndrome
  • +13 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Nov 2, 2022

Primary Myelofibrosis Trial in Japan (Fedratinib)

Recruiting
  • Primary Myelofibrosis
  • Suwa, Nagano, Japan
  • +25 more
Jan 18, 2023

A Prospective, Two-arm, Non-interventional Study of JAKAVI® in

Active, not recruiting
  • Primary Myelofibrosis
  • +2 more
  • Jakavi
  • Aachen, Germany
    Novartis Investigative Site
Sep 6, 2021

Thrombocythemia, Essential, Primary Myelofibrosis Trial in Worldwide (Bomedemstat)

Enrolling by invitation
  • Thrombocythemia, Essential
  • Primary Myelofibrosis
  • Miami, Florida
  • +18 more
Jan 30, 2023

Essential Thrombocythemia Trial in Tours (Anagrelide, Ruxolitinib (JAKAVI®), IFNa/ PegIFNa)

Terminated
  • Essential Thrombocythemia
  • Tours, France
    FILO
Jun 28, 2021

Idiopathic Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis, Post Polycythemia-Vera Myelofibrosis Trial in Worldwide

Completed
  • Idiopathic Myelofibrosis
  • +2 more
  • Paris, France
  • +9 more
Jun 22, 2021

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Philadelphia (procedure, drug, radiation)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +15 more
  • Hematopoietic Cell Transplantation
  • +7 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Apr 1, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

Active, not recruiting
  • Acute Myeloid Leukemia
  • +9 more
  • Los Angeles, California
  • +5 more
Jan 27, 2023

Acute Myeloid Leukemia, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Farmington Hills, Sterling Heights

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Farmington Hills, Michigan
  • +1 more
Jun 5, 2021

Myelofibrosis, Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis Trial in Hangzhou (Jaktinib HCl tablets)

Recruiting
  • Myelofibrosis
  • +3 more
  • Jaktinib hydrochloride tablets
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital of Medical School of Zhejiang Univ
Jun 11, 2021

Essential Thrombocythemia Trial in Korea, Republic of (Anagre Cap.)

Completed
  • Essential Thrombocythemia
  • Anagre Cap.
  • Goyang, Gyeonggi, Korea, Republic of
  • +20 more
Jul 20, 2021

Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide

Completed
Has Results
  • Primary Myelofibrosis
  • +4 more
  • Scottsdale, Arizona
  • +21 more
Jan 18, 2021

Essential Thrombocythaemia Trial in Spain, Sweden, United Kingdom (anagrelide HCl)

Completed
Has Results
  • Essential Thrombocythaemia
  • anagrelide hydrochloride
  • Barcelona, Spain
  • +4 more
Jun 7, 2021

Essential Thrombocythemia, Polycythemia Vera Trial in Boston (Ruxolitinib)

Not yet recruiting
  • Essential Thrombocythemia
  • Polycythemia Vera
  • Boston, Massachusetts
  • +2 more
Nov 24, 2020

Chronic Phase Myelofibrosis, Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Boston, Bronx, New

Completed
Has Results
  • Chronic Phase Myelofibrosis
  • +3 more
  • Boston, Massachusetts
  • +2 more
May 27, 2021

Patients With ET Treated With XAGRID®

Completed
Has Results
  • Essential Thrombocythemia (ET)
  • Anagrelide hydrochloride
  • Bari, Italy
  • +9 more
Jul 6, 2021

MPN (Myeloproliferative Tumors) Trial in United States (Ruxolitinib, Anagrelide, Placebo)

Terminated
Has Results
  • MPN (Myeloproliferative Neoplasms)
  • Phoenix, Arizona
  • +25 more
Oct 21, 2021

Primary Myelofibrosis, Myelofibrosis, PMF Trial (MBG453, NIS793, Spartalizumab)

Withdrawn
  • Primary Myelofibrosis
  • +4 more
  • (no location specified)
Mar 2, 2021

Myelofibrosis Due to and Following Polycythemia Vera Trial in United States (Ruxolitinib, Abemaciclib)

Recruiting
  • Myelofibrosis Due to and Following Polycythemia Vera
  • Basking Ridge, New Jersey
  • +6 more
Jan 26, 2023

Polycythaemia Vera and Essential Thrombocythaemia: Influence on

Completed
  • Polycythemia Vera
  • Thrombocythemia, Essential
  • No cytoreductive vs cytoreductive drugs
  • Geneva, Switzerland
  • +1 more
Nov 9, 2020